Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10172885 Cell

Patent 10172885 was granted and assigned to UCL Business on January, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
‌
UCL Business
0
Date Filed
November 21, 2014
0
Date of Patent
January 8, 2019
0
Patent Applicant
‌
UCL Business
0
Patent Application Number
15037405
0
Patent Citations Received
‌
US Patent 11458167 Bispecific CAR T-cells for solid tumor targeting
‌
US Patent 11492408 Bi-specific T-cell engager specific for BCMA
‌
US Patent 11602543 Compositions and methods for treating mesothelin positive cancers
‌
US Patent 11602544 Compositions and methods for treating EGFR positive cancers
‌
US Patent 11254726 LILRB1-based chimeric antigen receptor
‌
US Patent 11408005 Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
‌
US Patent 11433100 Compositions and methods for treating ceacam positive cancers
0
‌
US Patent 12005081 Chimeric receptors and methods of use thereof
0
‌
US Patent 10654927 Signalling system
Patent Inventor Names
Shaun Cordoba
0
Khai Kong
0
Martin Pulé
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10172885
0
Patent Primary Examiner
‌
Anne Marie S. Wehbe′
0

Find more entities like US Patent 10172885 Cell

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.